Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 37682870.
- Also identified by DOI 10.1093/infdis/jiad386 and PMC identifier 11095528.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A systematic review of randomized and observational studies from 2013 to 2023 demonstrated that antiviral preemptive therapy started at cytomegalovirus viral load thresholds between 2 and 3 log10 IU/mL was associated with similar cytomegalovirus disease rates. Thus, viral thresholds in this range appear to effectively protect patients not receiving prophylaxis.
Medical subject headings
- Cytomegalovirus Infections
- Viral Load
- Hematopoietic Stem Cell Transplantation
- Cytomegalovirus
- Antiviral Agents